Comparar métodos

	Cuestionario de Severidad de la Dependencia del Alcohol (SADQ)	Monitor Breve de Adicción (BAM)	Test de Identificación del Trastorno por Uso de Cannabis
Campo	Medicina de las adicciones	Medicina de las adicciones	Medicina de las adicciones
Familia	Process / pipeline	Process / pipeline	Process / pipeline
Año de origen	1979	2013	2010
Autor original	Stockwell, Murphy, Hodgson	Cacciola, Alterman, Drapkin, Valadez	Adamson, Kay-Lambkin, Baker, Lewin, Thornton, Kelly, Sellman
Tipo	Self-report	Self-report	Self-report
Fuente seminal	Stockwell, T., Murphy, D., & Hodgson, R. (1983). The Severity of Alcohol Dependence Questionnaire: Its use, reliability and validity. British Journal of Addiction, 78(2), 145–155.	Cacciola, J. S., Alterman, A. I., Drapkin, M. L., & Valadez, C. (2013). Development and initial validation of the Brief Addiction Monitor (BAM). Journal of Substance Abuse Treatment, 44(3), 256–263.	Adamson, S. J., Kay-Lambkin, F. J., Baker, A. L., Lewin, T. J., Thornton, L., Kelly, B. J., & Sellman, J. D. (2010). An improved brief screening instrument for cannabis use disorder. Drug and Alcohol Dependence, 110(1–2), 55–60.
Alias	SADQ	BAM	CUDIT-R, CUDIT
Relacionados	4	4	4
Resumen	The SADQ is a 20-item self-report instrument that measures the severity of alcohol dependence on a continuum from mild to severe. Developed by Stockwell and colleagues in 1979, it quantifies physical withdrawal symptoms, psychological dependence, and behavioral indicators of dependence to guide treatment intensity and medical management decisions. The SADQ remains a widely used assessment tool in addiction medicine and alcohol treatment settings.	The BAM is a 17-item self-report instrument designed to provide rapid, multimodal assessment of substance use, craving, risk factors, protective factors, and psychosocial functioning in individuals receiving addiction treatment. Developed by Cacciola and colleagues in 2013, it serves as an efficient outcome monitoring tool for tracking treatment progress, identifying relapse warning signs, and guiding therapeutic adjustments. The BAM is useful in treatment settings where frequent assessment of multiple domains is needed to optimize care.	The CUDIT-R is a brief, 8-item self-report screening instrument developed to identify cannabis use disorder and hazardous cannabis use patterns. Introduced by Adamson and colleagues in 2010 as a revision of the original CUDIT, the CUDIT-R improves brevity and screening efficiency while maintaining strong psychometric properties. It is designed for use in primary care, addiction treatment, and public health settings to detect problematic cannabis use and inform treatment allocation decisions.